STOCK TITAN

Translational Development Acquisition Units (TDACU) Stock Price, News & Analysis

TDACU NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
11 26 sessions, October 6, 2025 to October 13, 2026
Largest daily move
+65.6% close of May 26, 2026
1-year change
+10% closing prices, October 6, 2025 to October 13, 2026

Company Description

Translational Development Acquisition Units (NASDAQ: TDACU) is classified in the shell companies industry within the Financial Services sector.

TDACU has gained 10.0% over the past year. The last closing price was $11.48.

For FY2025, Translational Development Acquisition Units reported net income of $6.4M.

This page collects what Stock Titan holds for TDACU, including price data, latest news, SEC filings, financial highlights, and short interest trends.

Stock Performance

$—
-
-
Last updated:
+10%
Performance 1 year

Translational Development Acquisition Units (TDACU) closed at $11.48 on October 13, 2026. Over the past 12 months, the price has gained 10.0%.

See what a $1,000 investment in TDACU would be worth today

Average down calculator for TDACU

TDACU Metrics & Rankings

Price returns through October 13, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

Translational Development Acquisition Units has 10 recent news articles. Of the recent coverage, 8 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, IPO, offering. View all TDACU news →

Financial Highlights

operating income reached -$945K, and net income was $6.4M. The company generated -$608K in operating cash flow. The current ratio was 0.07, measuring current assets divided by current liabilities.

$6.4M
Net Income (FY2025)
-$608K
Operating Cash Flow
—
Revenue (FY2025)

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Translational Development Acquisition Units (TDACU) currently stands at 3 shares, down 50.0% from the previous reporting period. Since November 2025, short interest has increased by 200.0%.

Days to Cover History

Last 12 Months

Days to cover for Translational Development Acquisition Units (TDACU) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 3.0 days.

TDACU Company Profile & Sector Positioning

Translational Development Acquisition Units (TDACU) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NASDAQ.

Investors comparing TDACU often look at related companies in the same sector, including Bold Eagle Acquisition Corp. Units (BEAGU), Aldel Financial II Inc. Units (ALDFU), Cayson Acquisition Corp Unit (CAPNU), Charlton Aria Acquisition Corporation Units (CHARU), and Future Vision II Acquisition Corporation Units (FVNNU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TDACU's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Translational Development Acquisition Units (TDACU)?

The current stock price of Translational Development Acquisition Units (TDACU) is $11.48 as of October 13, 2026.

What is the net income of Translational Development Acquisition Units (TDACU)?

The FY2025 net income of Translational Development Acquisition Units (TDACU) is $6.4M, from its most recent completed fiscal year.

What is the operating cash flow of Translational Development Acquisition Units (TDACU)?

The operating cash flow of Translational Development Acquisition Units (TDACU) is -$608K for FY2025, its most recent completed fiscal year. Learn about cash flow.

What is the current ratio of Translational Development Acquisition Units (TDACU)?

The current ratio of Translational Development Acquisition Units (TDACU), current assets divided by current liabilities, was 0.07 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

What is the operating income of Translational Development Acquisition Units (TDACU)?

The operating income of Translational Development Acquisition Units (TDACU) is -$945K for FY2025, its most recent completed fiscal year. Learn about operating income.